InMode rises after Q4 prelim profit beats estimates
** Israel-based medtech company InMode's INMD.O shares
rise 1.8% to $21.15 premarket
** Company posts Q4 prelim adj profit of 68 to 69 cents per
share vs est 63 cents/shr - LSEG data
** InMode expected to report Q4 and full year 2023 results
on Feb. 13
** Company's shares fell 37.7% in 2023
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Recent news on InMode
See all newsBrief: Inmode Haifa District Court Denied Sp Strategic Holdings' Request For Temporary Injunctive Relief In Its Entirety
InMode Ltd. reports results for the quarter ended June 30 - Earnings Summary
Brief: Inmode Q2 Revenue USD 95.589 Million Versus. Ibes Estimate USD 93 Million
InMode Q2 revenue beats estimates on steady U.S. demand
Brief: Steel Partners Urges Inmode Shareholders To Vote Against The Re-Election Of Dr. Hadar Ron And Against Extraordinary Special Committee Compensation At The July 30 Annual General Meeting